Cancer experts put focus on targeted molecular therapies
AFP, June, 2006
 | Content provided in partnership with |  |
ATLANTA, United States (AFP) — Targeted molecular therapies, promising treatments that act on genetic and biochemical mechanisms, are the darlings of cancer experts gathered this weekend at the congress of the American Society of Clinical Oncology.
It is the world's largest gathering of oncologists, and drug manufacturers are jostling to sell their anti-cancer treatments, to a market worth 15 billion dollars.
Researchers are currently evaluating more advanced treatment options such as gene therapy, hormone therapy and targeted molecular therapies (single and multiple).
- Most Popular Articles in News
- The Ten Best Laptop bags
- Tata plans cheapest-ever car for Indian market
- GLOBALIZATION AND THE DEVELOPMENT OF UNDERDEVELOPMENT OF THE THIRD WORLD
- Corn is good for you; Corn is not only a tasty treat, but also a cereal that ...
- THE 50 BEST STYLISH HANDBAGS TO CARRY
- More »
The molecular therapies -- for which some clinical test results were to be announced here -- apparently are the most promising because they block pathways and vital functions of cancerous cells, killing them.
They are aimed at supplementing key cancer treatment tools such as radiation, used to destroy or damage cancer cells using high energy x-rays; chemotherapy, or using drugs to eliminate cancer cells by interfering with their ...
Find Research Guides for:
Find Featured Titles for: Reference
- Academe
- African American Review
- African Arts
- African Studies Review
- Afro-Americans in New York Life and History
- Alabama Heritage
- Alabama Review
- American Mathematical Monthly, The
- Anglican Theological Review
- Annals of Dyslexia
- Arab Studies Quarterly (ASQ)
- Auk, The
- Australian Journal of Anthropology, The
- Christian Century
- Natural History